The Traderszone Network

Published in TZ Latest News 15 June, 2014 by The TZ Newswire Staff

Why Shorts Are Betting Against Enanta Pharmaceuticals

Shares of Enanta Pharmaceuticals have surged heading in a pivotal regulatory review of the company’s lead hepatitis C therapy. Short-sellers apparently don’t share the market’s outlook and have started moving into the stock. Should you be worried?

read more